The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
Marks significant milestone for breakthrough biologic to treat rare blood cancers
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
This license is a key regulatory milestone in advancing Hester's prevention-led poultry healthcare portfolio
InflaRx is streamlining operations and largely discontinuing non-essential activities outside izicopan’s development
Astal estimates the collaboration will generate incremental revenue of approximately Rs. 300 crore upon implementation
The decision is based on robust clinical evidence from the VOYAGE and EXCURSION studies
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Subscribe To Our Newsletter & Stay Updated
